Zimmer Biomet Holdings, Inc., a global medical technology leader, has announced that it has received the CE Mark for its Persona Revision Knee System. This certification allows the company to expand the availability of the Persona Revision Knee System to more surgeons in Europe and other markets.
The Persona Revision Knee System is an advanced tool for revision knee arthroplasty, providing surgeons with personalized solutions to enhance patient outcomes. It offers a personalized fit and optimized function for patients undergoing revision knee surgery. The modular system allows for intraoperative flexibility, enabling surgeons to address a wide range of complex cases with precision and ease.
One of the key features of the Persona Revision Knee System is Zimmer Biomet’s proprietary Trabecular MetalTM Technology, which promotes long-term bone in-growth and improves implant fixation. This technology has been proven to enhance the stability, mobility, and longevity of the implant.
With the CE Mark certification, Zimmer Biomet aims to expand its industry-leading knee portfolio and provide surgeons and patients with a system that is truly personalized, adaptable, and designed to restore natural knee motion. The Persona Revision Knee System is already the leading product in the over $700 million U.S. knee revision market.
The system’s anatomic components and intuitive instrumentation streamline the revision surgery process, reducing complexity while improving precision. Surgeons can make intraoperative adjustments to achieve optimal alignment and fit for each patient, further enhancing the overall outcome.
Zimmer Biomet’s mission is to alleviate pain and improve the quality of life for patients worldwide through innovative and clinically proven solutions. The Persona Revision Knee System is a testament to this commitment, offering surgeons and patients a personalized and adaptable solution for revision knee arthroplasty.
For more information on the Persona Revision Knee System and Zimmer Biomet’s comprehensive portfolio of orthopedic products, visit their official website.
About Zimmer Biomet:
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. With operations in over 25 countries and sales in more than 100 countries, Zimmer Biomet is dedicated to delivering the highest quality solutions to patients and providers. The company leverages data, data analytics, and artificial intelligence to transform the patient experience and drive innovation in the field of medical technology.
Cautionary Statement Regarding Forward-Looking Statements:
Zimmer Biomet cautions that this news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially. Readers are advised to refer to Zimmer Biomet’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC) for a list and description of some of these risks and uncertainties.